Thrombopoietin Receptor Agonists in the Treatment of Chronic Resistant Primary Immune Thrombocytopenia: Efficacy and Safety Data in Real Clinical Practice

by V V PTUSHKIN, O Yu VINOGRADOVA, M M PANKRASHKINA, M V CHERNIKOV, E G ARSHANSKAYA, N E TKACHENKO
Published 2018-07-01

Combination of bendamustine and rituximab in the management of relapsed and refractory chronic lymphocytic leukemia: the results of retrospective study

by S. V. Semochkin, E. G. Arshanskaya, O. D. Zakharov, A. N. Kotelnikova, S. S. Kulikova, E. V. Ovanesova, Yu. B. Kochkareva, V. L. Ivanova
Published 2015-06-01

Combination of bendamustine and rituximab in the management of relapsed and refractory chronic lymphocytic leukemia: the results of retrospective study

by S. V. Semochkin, E. G. Arshanskaya, O. D. Zakharov, A. N. Kotelnikova, S. S. Kulikova, E. V. Ovanesova, Yu. B. Kochkareva, V. L. Ivanova
Published 2015-06-01